Literature DB >> 7865270

Urinary N-acetyl-beta-D-glucosaminidase excretion in term and preterm neonates.

H Tsukahara1, C Hori, S Tsuchida, M Hiraoka, M Sudo, S Haruki, F Suehiro.   

Abstract

Urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion was measured in term and preterm neonates on days 1, 4, 7, 14 and 28 of life. Urinary NAG showed a peak level on day 4 or 7 in these infants. In addition, it tended to be higher with the degree of prematurity. In sick preterms who were depressed at birth and had respiratory failure, the NAG activity was further elevated during the first 2 weeks, suggesting the presence of renal tubular injury in this period. These observations thus suggest that urinary NAG may be a sensitive measure of renal maturation or damage in neonates.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7865270     DOI: 10.1111/j.1440-1754.1994.tb00729.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  4 in total

1.  Urinary uric acid excretion and renal function in newborn infants.

Authors:  H Tsukahara; A Kiyohara; K Kimura; K Fujisawa; Y Konishi; M Sudo
Journal:  Eur J Pediatr       Date:  1996-09       Impact factor: 3.183

2.  Biochemical parameters of renal impairment/injury and surrogate markers of nephron number in intrauterine growth-restricted and preterm neonates at 30-40 days of postnatal corrected age.

Authors:  Maria Cristina Aisa; Benito Cappuccini; Antonella Barbati; Aldo Orlacchio; Mauro Baglioni; Gian Carlo Di Renzo
Journal:  Pediatr Nephrol       Date:  2016-08-25       Impact factor: 3.714

3.  Evaluation of renal functions in preterm infants with respiratory distress syndrome.

Authors:  Yılmaz Tabel; Mehmet Oncül; Ahmet Taner Elmas; Serdal Güngör
Journal:  J Clin Lab Anal       Date:  2014-02-27       Impact factor: 2.352

4.  Evaluation of urinary enzymes in newborns treated with gentamicin.

Authors:  Ali Mohammadi Karakani; Solmaz Asgharzadeh Haghighi; Mahmoud Ghazi-Khansari; Afsaneh Seyed-Ebrahimi; Sharareh Zeighami-Mohammadi
Journal:  Iran J Basic Med Sci       Date:  2014-05       Impact factor: 2.699

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.